Free Trial

Cingulate (CINGW) Competitors

$0.04 0.00 (-4.05%)
As of 02:38 PM Eastern

CINGW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Cingulate stock or one of its competitors? The main competitors of Cingulate include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Cingulate vs.

Cingulate (NASDAQ:CINGW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, community ranking, profitability, media sentiment, analyst recommendations, risk and institutional ownership.

In the previous week, Cingulate's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Cingulate Neutral
180 Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
CingulateN/A N/A N/A
180 Life Sciences N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CingulateN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Cingulate and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
CingulateN/AN/A
180 Life SciencesN/AN/A

Summary

Cingulate and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Get Cingulate News Delivered to You Automatically

Sign up to receive the latest news and ratings for CINGW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CINGW vs. The Competition

MetricCingulateBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$120.45M$5.41B$7.70B
Dividend YieldN/A3.69%5.44%4.33%
P/E RatioN/A3.0022.2418.31
Price / SalesN/A4,171.18394.02105.72
Price / CashN/A13.0238.2034.62
Price / BookN/A34.436.784.23
Net IncomeN/A-$90.45M$3.21B$247.51M
7 Day PerformanceN/A1.39%5.03%5.68%
1 Month PerformanceN/A-3.85%-6.18%-4.10%
1 Year PerformanceN/A89.73%16.18%4.41%

Cingulate Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CINGW
Cingulate
N/A$0.04
-4.1%
N/A+146.7%$0.00N/A0.0020Gap Up
ATNFW
180 Life Sciences
N/A$0.01
-2.6%
N/A-22.2%$0.00N/A0.007
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
+2.5%
N/A-74.2%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.08
-2.4%
N/A+37.8%$0.00$20,729.000.0040Gap Down
ALVOW
Alvotech
N/A$1.11
-14.6%
N/A-58.8%$0.00$489.68M0.004Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
flat
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.07
+7.7%
N/A-8.2%$0.00$37.32M0.0070
BTMDW
biote
N/A$0.02
-34.7%
N/A-93.2%$0.00$197.19M0.00N/AGap Down
High Trading Volume
BCTXW
BriaCell Therapeutics
N/A$0.09
flat
N/A-84.7%$0.00N/A0.008Gap Down
CELUW
Celularity
N/A$0.04
-0.3%
N/A+9.4%$0.00$48.20M0.00220

Related Companies and Tools


This page (NASDAQ:CINGW) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners